ABVC BioPharma, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-3.5M | $-3.5M | — | $398.0K |
| FY2017 | $-1.6M | $-1.5M | — | $155.4K |
| FY2018 | $-900.5K | $-900.5K | — | $28.8K |
| FY2019 | $-3.1M | $-3.1M | — | $22.3K |
| FY2020 | $-4.6M | $-4.6M | — | $4.1M |
| FY2021 | $-7.6M | $-7.6M | $17.5K | $5.3M |
| FY2022 | $-7.4M | $-7.5M | $119.7K | $7.0M |
| FY2023 | $-4.2M | $-4.2M | $21.2K | $185.9K |
| FY2024 | $-1.8M | $-1.8M | — | $2.8M |
| FY2025 | $-3.0M | $-3.0M | — | $4.1M |